Company Filing History:
Years Active: 2009
Title: Mark S Sliwkowski: Innovator in Heregulin Variants
Introduction
Mark S Sliwkowski is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of heregulin variants. His work has implications for cancer research and therapeutic applications.
Latest Patents
Mark S Sliwkowski holds a patent for "Heregulin variants." This invention provides heregulin variants that are capable of binding an ErbB receptor. The patent includes variants of human heregulins, specifically variants of human heregulin-β1 that have enhanced affinity for the ErbB-3 and ErbB-4 receptors. These variants include at least one amino acid substitution and can incorporate further modifications. The invention also encompasses nucleic acid molecules encoding heregulin variants, related vectors, host cells, pharmaceutical compositions, and methods.
Career Highlights
Mark S Sliwkowski is associated with Genentech, Inc., a leading biotechnology company. His work at Genentech has allowed him to focus on innovative solutions in the field of molecular biology and therapeutic development.
Collaborations
Some of his notable coworkers include Marcus D Ballinger and Jennifer T Jones. Their collaborative efforts contribute to the advancement of research and development in biotechnology.
Conclusion
Mark S Sliwkowski's contributions to the field of heregulin variants highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the development of targeted therapies in oncology.